About
Autologous Cell Therapy, Contract Cell Therapy Manufacturing
Areas of Focus
Categories
Stem Cell & Cellular TherapyContract ManufacturingSan Diego & Southern California
Clinical Trials (30)
View allTotal Trials
30
As Lead Sponsor
20
As Collaborator
10
Total Enrollment
5,226
By Phase
PHASE2: 16PHASE1: 3PHASE3: 5NA: 2
By Status
COMPLETED: 21TERMINATED: 5RECRUITING: 4
Clinical Trials Pipeline30 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
Today
Hover over trial bars to see details
Recent Trials
NCT06100705Collaborator
Sipuleucel-T Combined with Bipolar Androgen Therapy in Men with MCRPC
PHASE2Recruiting
26 participants
Started: Dec 20, 2023 · Completed: Mar 31, 2028
NCT05806814Collaborator
Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer
PHASE1Recruiting
13 participants
Started: Nov 12, 2023 · Completed: Dec 31, 2026
NCT06134232Lead Sponsor
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
PHASE2Recruiting
400 participants
Started: Oct 2, 2023 · Completed: Jun 30, 2032
NCT05751941Collaborator
Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer
PHASE2Recruiting
26 participants
Started: Feb 14, 2023 · Completed: Dec 31, 2026
NCT03686683Lead Sponsor
Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer
PHASE3Completed
532 participants
Started: Oct 18, 2018 · Completed: Mar 10, 2023
Locations (1)
Headquarters
Seal Beach, CA, United States
Map
Loading map...